Warby Parker Inc. (WRBY): Total Liabilities
$353.19M
As of 2025-12-31
$380.33M
As of 2026-06-30
+7.8%
3-year compound annual growth
+21.0%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $353.19M | +5.0% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $336.42M | +20.8% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $278.52M | -1.3% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $282.06M | +82.4% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $154.65M | +13.4% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $136.34M | n/a | 2022-03-18, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Warby Parker Inc. (WRBY) | 2025-12-31 | $353.19M | +5.0% |
| Staar Surgical Co (STAA) | 2026-01-02 | $107.49M | -4.2% |
| Cooper Companies, Inc. (COO) | 2025-10-31 | $4.16B | -1.8% |
| Bausch & Lomb Corp (BLCO) | 2025-12-31 | $7.50B | +8.3% |
| RxSight, Inc. (RXST) | 2025-12-31 | $36.13M | -3.2% |
| Innovative Eyewear Inc (LUCY) | 2025-12-31 | $1.07M | +44.5% |
Compare WRBY, STAA, COO, BLCO side by side · Screen every company in Ophthalmic Goods ↗